Detalhe da pesquisa
1.
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lancet
; 403(10432): 1141-1152, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461841
2.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Lancet
; 403(10432): 1153-1163, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461843
3.
Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA Study.
Ophthalmology
; 126(8): 1171-1180, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30946887
4.
Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema: Post Hoc Analyses from VISTA and VIVID.
Ophthalmology
; 125(1): 51-56, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28764888
5.
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
Ophthalmology
; 123(4): 850-7, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26832658
6.
Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid.
Ophthalmology
; 123(9): 1856-64, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27369111
7.
Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled Trials.
Ophthalmology
; 123(7): 1511-20, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084563
8.
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.
Ophthalmology
; 123(2): 330-336, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26522708
9.
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Ophthalmology
; 123(11): 2376-2385, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27651226
10.
Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study.
Ophthalmology
; 122(3): 538-44, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25315663
11.
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
Ophthalmology
; 122(10): 2044-52, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26198808
12.
Microperimetric assessment of retinal sensitivity in eyes with diabetic macular edema from a phase 2 study of intravitreal aflibercept.
Retina
; 35(4): 687-94, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25621943
13.
Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study.
Ophthalmology
; 121(1): 202-208, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24084497
14.
Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study.
Ophthalmology
; 121(7): 1414-1420.e1, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24679444
15.
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
Ophthalmology
; 121(1): 193-201, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24084500
16.
Intravitreal aflibercept for diabetic macular edema.
Ophthalmology
; 121(11): 2247-54, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25012934
17.
Functional outcomes of sustained improvement on Diabetic Retinopathy Severity Scale with intravitreal aflibercept in the VISTA and VIVID trials.
Eye (Lond)
; 37(10): 2020-2025, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440699
18.
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
JAMA Ophthalmol
; 141(9): 834-842, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535382
19.
Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study.
Ophthalmology
; 119(5): 1024-32, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22440275
20.
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.
Ophthalmology
; 119(8): 1658-65, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22537617